Natick, MA, United States of America

Richard Wooster

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Richard Wooster: Innovator in Targeted Therapeutics

Introduction

Richard Wooster, an accomplished inventor based in Natick, MA, has made significant strides in the field of therapeutic compounds and delivery systems. With a remarkable portfolio of 11 patents, his innovations are focused on enhancing the efficacy of treatments, particularly in the oncology and infectious diseases sectors.

Latest Patents

Among Richard Wooster's latest patents are several groundbreaking inventions that explore HSP90 targeted conjugates and particles. These inventions involve the development of conjugates that link therapeutic, prophylactic, or diagnostic agents to an HSP90 targeting moiety through a linker. This design aims to improve the temporospatial delivery and biodistribution of active agents. His patents include methods for crafting these conjugates, nanoparticles, and microparticles, as well as methods for administering these formulations to treat or prevent diseases such as cancer and infectious conditions. Wooster's innovations hold the potential to revolutionize how treatments are delivered to patients, significantly impacting the effectiveness of therapeutic interventions.

Career Highlights

Richard has contributed his expertise to esteemed companies in the biotechnology sector, notably Tarveda Therapeutics, Inc. and Placon Therapeutics, Inc. His work in these organizations showcases his dedication to advancing targeted therapies. With a focus on innovative drug delivery systems, he has played a vital role in research and development processes aimed at providing improved treatment options.

Collaborations

Throughout his career, Richard Wooster has collaborated with notable colleagues, including Mark T. Bilodeau and Rajesh R. Shinde. Together with these professionals, he has pursued cutting-edge research that furthers the understanding and application of targeted therapeutics.

Conclusion

Richard Wooster's contributions to the field of targeted therapeutics underscore his position as an innovative inventor. Through his patents and collaborative efforts, he continues to pave the way for advancements in medical treatments that can enhance patient outcomes. His work exemplifies the spirit of innovation that drives the biotechnology industry forward.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…